We transfected these siRNAs into MIA PaCa-2 pancreatic carcinoma cells (KRASG12C/WT) to identify the most potent based on reduced MYC mRNA and protein expression. The gene discussed is MYC; the disease is exocrine pancreatic carcinoma.